Citations

Showing 10 of 108119 citations.

Chimeric RNA: DNA TracrRNA Improves Homology-Directed Repair In Vitro and In Vivo
Simone, Brandon W. , Daby, Camden L. , Ata, Hirotaka , Restrepo-Castillo, Santiago , Kar, Bibekananda , Gendron, William A.C. , Martínez-Gálvez, Gabriel, Kar, Bibekananda , Castillo, Santiago R , Lee, Han , Martínez‐Gálvez, Gabriel , Clark, Karl J. , Ekker, Stephen C.

Mayo Clinic

The CRISPR Journal | December 22, 2021 | Volume: 5 | Issue: 1 | Pages: 40-52

10.1089/crispr.2021.0087 | PMID 34935462 Get It

Nearly 90% of human pathogenic mutations are caused by small genetic variations, and methods to correct these errors efficiently are critically important. One way to make small DNA changes is providing a single-stranded oligo deoxynucleotide (ssODN) containing an alteration coupled with a targeted double-strand break (DSB) at the target locus in the genome. Coupling an ssODN donor with a CRISPR-Cas9-mediated DSB is one of the most streamlined approaches to introduce small changes. However, in many systems, this approach is inefficient and introduces imprecise repair at the genetic junctions. We herein report a technology that uses spatiotemporal localization of an ssODN with CRISPR-Cas9 to improve gene alteration. We show that by fusing an ssODN template to the trans-activating RNA (tracrRNA), we recover precise genetic alterations, with increased integration and precision in vitro and in vivo . Finally, we show that this technology can be used to enhance gene conversion with other gene editing tools such as transcription activator like effector nucleases.
Letter: Haptics in Neurosurgery: A Much-Needed Tool for Neurosurgery Training
Ghozy, Sherief , Negida, Ahmed , Ghozy, Sherief , Azzam, Ahmed Y , Negida, Ahmed

Mayo Clinic

Neurosurgery | December 22, 2021 | Volume: 90 | Issue: 3 | Pages: e76-e77

10.1227/neu.0000000000001796 | PMID 34995254 Get It

Reliable Assessment of Swine Renal Fibrosis Using Quantitative Magnetization Transfer Imaging
Jiang, Kai , Ferguson, Christopher M. , Grimm, Roger C., Zhu, Xiangyang , Glockner, James F., Lerman, Lilach O.

Mayo Clinic

Investigative Radiology | December 22, 2021 | Volume: 57 | Issue: 5 | Pages: 334-342

10.1097/rli.0000000000000843 | PMID 34935650 Get It

Objectives Quantitative magnetization transfer (qMT) is useful for measurement of murine renal fibrosis at high and ultrahigh field strengths. However, its utility at clinical field strengths and in human-like kidneys remains unknown. We tested the hypothesis that qMT would successfully detect fibrosis in swine kidneys with unilateral renal artery stenosis (RAS) at 3.0 T. Methods The qMT protocol is composed of MT scans with variable flip angles and offset frequencies, and of B0 , B1 , and T1 mapping. Pigs were scanned 10 weeks after RAS or control. A 2-pool model was used to fit the bound pool fraction f of the renal cortex (CO) and outer medulla (OM). Then qMT-derived f in 5 normal and 10 RAS pigs was compared with histological fibrosis determined using Masson's trichrome staining and to renal perfusion assessed with computed tomography. Results The qMT 2-pool model provided accurate fittings of data collected on swine kidneys. Stenotic kidneys showed significantly elevated f in both the CO (9.8% ± 2.7% vs 6.4% ± 0.9%, P = 0.002) and OM (7.6% ± 2.2% vs 4.7% ± 1.1%, P = 0.002), as compared with normal kidneys. Histology-measured renal fibrosis and qMT-derived f correlated directly in both the cortex (Pearson correlation coefficient r = 0.93, P < 0.001) and OM (r = 0.84, P = 0.002), and inversely with stenotic kidney perfusion (r = 0.85, P = 0.002). Conclusions This study demonstrates the feasibility of qMT for measuring fibrosis in human-like swine kidneys, and the association between tissue macromolecule content and renal perfusion. Therefore, qMT may be useful as a tool for noninvasive assessment of renal fibrosis in subjects with RAS at clinical field strengths.
Effective Use of Lidocaine With Epinephrine During a Nationwide Shortage
Fathizadeh, Sam, Rorex, Jennifer N. , Fathi, Ramin, Fathizadeh, Sam

Mayo Clinic

Dermatologic Surgery | December 22, 2021 | Volume: 48 | Issue: 2 | Pages: 265-265

10.1097/dss.0000000000003346 | PMID 34935747 Get It

A fatal case of malignant atrophic papulosis in a pediatric patient
Schaefer, Lauren , Muskardin, Theresa Wampler , Tillema, Jan‐Mendelt , Wieland, Carilyn N. , Tollefson, Megha M. , Schaefer, Lauren S , Wieland, Carilyn

Mayo Clinic

Pediatric Dermatology | December 22, 2021 | Volume: 39 | Issue: 1 | Pages: 112-114

10.1111/pde.14878 | PMID 34935194 Get It

AbstractA 17‐year‐old Caucasian boy presented with progressive left‐sided weakness, transient slurred speech, and skin lesions characterized by 3‐5 mm, pink, asymptomatic papules with white atrophic centers on his central abdomen, back, and lower extremities. Skin biopsy confirmed the diagnosis of malignant atrophic papulosis, a rare vasculopathy that leads to the occlusion of small‐ and medium‐sized arteries. He was treated with cyclophosphamide, eculizumab, treprostinil, pentoxifylline, heparin, and acetylsalicylic acid. Despite the aggressive immunosuppression, humanized monoclonal antibodies, and antiplatelet therapy, he died two months after presentation. We report this case to highlight diagnostic features, as well as to highlight the importance of early diagnosis and treatment.
Encephalocele‐associated temporal lobe epilepsy and skull fibrous dysplasia: a report of two cases
Cox, Benjamin C. , Jones, Ojore O., Smith, Kelsey M. , Kotsenas, Amy L. , Gompel, Jamie J. Van , Burkholder, David B. , Wong‐Kisiel, Lily C.

Mayo Clinic

Epileptic Disorders | December 22, 2021 | Volume: 23 | Issue: 6 | Pages: 940-943

10.1684/epd.2021.1335 | PMID 34668858 Get It

Room tilt illusion in epilepsy
Fattal, Deema , Sainju, Rup K. , St Louis, Erik, Wattiez, Anne‐Sophie , Louis, Erik K. St. , Otárula, Karina A. González

Mayo Clinic

Epileptic Disorders | December 22, 2021 | Volume: 23 | Issue: 6 | Pages: 901-905

10.1684/epd.2021.1332 | PMID 34668857 Get It

AbstractRoom tilt illusion is a rare phenomenon in which a person transiently perceives the surrounding environment as tilted to one side. Epilepsy is one of the presumed causes of room tilt illusion, but this has never been proven. We present a case of room tilt illusion that is epileptic in nature, documented by video‐ EEG monitoring. Our Patient is a 30‐year‐old woman with 11 years history of bi‐monthly spells of sudden tilt of the whole environment counterclockwise for a duration of one to two seconds. These spells were initially diagnosed as psychogenic. She was then admitted to our video‐EEG monitoring unit. She had three of her typical spells during monitoring, with corresponding changes of brief generalized spike‐wave burst on EEG that coincided temporarily with her symptoms. The video otherwise did not reveal any sway or tilt of the patient herself. She was started on topiramate with resolution of her symptoms. She remained spell‐free when seen during follow‐up, six months later. This case illustrates a first example of room tilt illusion that is documented to be epileptic in nature. This case adds to the varied nature of how epilepsy can manifest in patients, which may support improved diagnosis and treatment of epileptic patients.
Post‐traumatic stress disorder, anxiety, and depression among adults with congenital heart defects
Downing, Karrie F. , Bobo, William V. , Grosse, Scott D. , Khanna, Amber , Farr, Sherry L. , Simeone, Regina M , Downing, Karrie F , V Bobo, William , Grosse, Scott D , Khanna, Amber D , Farr, Sherry L , Simeone, Regina M.

Mayo Clinic

Birth Defects Research | December 22, 2021 | Volume: 114 | Issue: 3-4 | Pages: 124-135

10.1002/bdr2.1971 | PMID 34935303 Get It

AbstractBackgroundDue to invasive treatments and stressors related to heart health, adults with congenital heart defects (CHDs) may have an increased risk of post‐traumatic stress disorder (PTSD), anxiety, and/or depressive disorders. Our objectives were to estimate the prevalence of these disorders among individuals with CHDs.MethodsUsing IBM® MarketScan® Databases, we identified adults age 18–49 years with ≥2 outpatient anxiety/depressive disorder claims on separate dates or ≥1 inpatient anxiety/depressive disorder claim in 2017. CHDs were defined as ≥2 outpatient CHD claims ≥30 days apart or ≥1 inpatient CHD claim documented in 2007–2017. We used log‐binomial regression to estimate adjusted prevalence ratios (aPR) and 95% confidence intervals (CI) for associations between CHDs and anxiety/depressive disorders.ResultsOf 13,807 adults with CHDs, 12.4% were diagnosed with an anxiety or depressive disorder. Adults with CHDs, compared to the 5,408,094 without CHDs, had higher prevalence of PTSD (0.8% vs. 0.5%; aPR: 1.5 [CI: 1.2–1.8]), anxiety disorders (9.9% vs. 7.5%; aPR: 1.3 [CI: 1.3–1.4]), and depressive disorders (6.3% vs. 4.9%; aPR: 1.3 [CI: 1.2–1.4]). Among individuals with CHDs, female sex (aPR range: 1.6–3.3) and inpatient admission (aPR range 1.1–1.9) were associated with anxiety/depressive disorders.ConclusionOver 1 in 8 adults with CHDs had diagnosed PTSD and/or other anxiety/depressive disorders, 30–50% higher than adults without CHDs. PTSD was rare, but three times more common in women with CHDs than men. Screening and referral for services for these conditions in people with CHDs may be beneficial.
Association Between Age and Outcomes of Catheter Ablation Versus Medical Therapy for Atrial Fibrillation: Results From the CABANA Trial
Bahnson, Tristram D. , Giczewska, Anna , Mark, Daniel B. , Russo, Andrea M. , Monahan, Kristi H. , Al‐Khalidi, Hussein R. , Silverstein, A , Poole, Jeanne E. , Lee, Kerry L., Packer, Douglas L. , Investigators, for the CABANA, Silverstein, Adam P , Mark, Daniel B , Investigators, for the CABANA

Mayo Clinic

Circulation | December 22, 2021 | Volume: 145 | Issue: 11 | Pages: 796-804

10.1161/circulationaha.121.055297 | PMID 34933570 Get It

Background: Observational data suggest that catheter ablation may be safe and effective to treat younger and older patients with atrial fibrillation. No large, randomized trial has examined this issue. This report describes outcomes according to age at entry in the CABANA trial (Catheter Ablation versus Antiarrhythmic Drug Therapy for Atrial Fibrillation). Methods: Patients with atrial fibrillation ≥65 years of age, or <65 with ≥1 risk factor for stroke, were randomly assigned to catheter ablation versus drug therapy. The primary outcome was a composite of death, disabling stroke, serious bleeding, or cardiac arrest. Secondary outcomes included all-cause mortality, the composite of mortality or cardiovascular hospitalization, and recurrence of atrial fibrillation. Treatment effect estimates were adjusted for baseline covariables using proportional hazards regression models. Results: Of 2204 patients randomly assigned in CABANA, 766 (34.8%) were <65 years of age, 1130 (51.3%) were 65 to 74 years of age, and 308 (14.0%) were ≥75 years of age. Catheter ablation was associated with a 43% reduction in the primary outcome for patients <65 years of age (adjusted hazard ratio [aHR], 0.57 [95% CI, 0.30–1.09]), a 21% reduction for 65 to 74 years of age (aHR, 0.79 [95% CI, 0.54–1.16]), and an indeterminate effect for age ≥75 years of age (aHR, 1.39 [95% CI, 0.75–2.58]). Four-year event rates for ablation versus drug therapy across age groups, respectively, were 3.2% versus 7.8%, 7.8% versus 9.6%, and 14.8% versus 9.0%. For every 10-year increase in age, the primary outcome aHR increased (ie, less favorable to ablation) an average of 27% (interaction P value=0.215). A similar pattern was seen with all-cause mortality: for every 10-year increase in age, the aHR increased an average of 46% (interaction P value=0.111). Atrial fibrillation recurrence rates were lower with ablation than with drug therapy across age subgroups (aHR 0.47, 0.58, and 0.49, respectively). Treatment-related complications were infrequent for both arms (<3%) regardless of age. Conclusions: We found age-based variations in clinical outcomes for catheter ablation compared with drug therapy, with the largest relative and absolute benefits of catheter ablation in younger patients. No prognostic benefits for ablation were seen in the oldest patients. No differences were found by age in treatment-related complications or in the relative effectiveness of catheter ablation in preventing recurrent atrial arrhythmias. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT00911508.
Successful recruitment and retention of academic physicians: hiring for longevity, productivity, and leadership in hospital medicine
Fischer, Karen M. , Coons, Trevor J. , Kashiwagi, Deanne T. , Elias, Richard M , Fischer, Karen M , Coons, Trevor , Kashiwagi, Deanne, Eliáš, Richard

Mayo Clinic

Hospital Practice | December 22, 2021 | Volume: 50 | Issue: 1 | Pages: 42-48

10.1080/21548331.2021.2022329 | PMID 34933645 Get It